Correlation Between Hepion Pharmaceuticals and Altamira Therapeutics
Can any of the company-specific risk be diversified away by investing in both Hepion Pharmaceuticals and Altamira Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hepion Pharmaceuticals and Altamira Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hepion Pharmaceuticals and Altamira Therapeutics, you can compare the effects of market volatilities on Hepion Pharmaceuticals and Altamira Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hepion Pharmaceuticals with a short position of Altamira Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hepion Pharmaceuticals and Altamira Therapeutics.
Diversification Opportunities for Hepion Pharmaceuticals and Altamira Therapeutics
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Hepion and Altamira is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Hepion Pharmaceuticals and Altamira Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Altamira Therapeutics and Hepion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hepion Pharmaceuticals are associated (or correlated) with Altamira Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Altamira Therapeutics has no effect on the direction of Hepion Pharmaceuticals i.e., Hepion Pharmaceuticals and Altamira Therapeutics go up and down completely randomly.
Pair Corralation between Hepion Pharmaceuticals and Altamira Therapeutics
Given the investment horizon of 90 days Hepion Pharmaceuticals is expected to generate 1.1 times more return on investment than Altamira Therapeutics. However, Hepion Pharmaceuticals is 1.1 times more volatile than Altamira Therapeutics. It trades about -0.07 of its potential returns per unit of risk. Altamira Therapeutics is currently generating about -0.18 per unit of risk. If you would invest 117.00 in Hepion Pharmaceuticals on September 3, 2024 and sell it today you would lose (54.00) from holding Hepion Pharmaceuticals or give up 46.15% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Hepion Pharmaceuticals vs. Altamira Therapeutics
Performance |
| Timeline |
| Hepion Pharmaceuticals |
| Altamira Therapeutics |
Hepion Pharmaceuticals and Altamira Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Hepion Pharmaceuticals and Altamira Therapeutics
The main advantage of trading using opposite Hepion Pharmaceuticals and Altamira Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hepion Pharmaceuticals position performs unexpectedly, Altamira Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Altamira Therapeutics will offset losses from the drop in Altamira Therapeutics' long position.| Hepion Pharmaceuticals vs. DiaMedica Therapeutics | Hepion Pharmaceuticals vs. Lyra Therapeutics | Hepion Pharmaceuticals vs. Centessa Pharmaceuticals PLC |
| Altamira Therapeutics vs. Pyxis Oncology | Altamira Therapeutics vs. Zura Bio Limited | Altamira Therapeutics vs. Elevation Oncology | Altamira Therapeutics vs. Immix Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |